RNA inhibitor is shown safe and effective in reducing a wide range of cholesterol and triglyceride levels in the blood
A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.
Source: medicalxpress.com
